Study Details

Back
Study ID 7991-CL-1004
Study Title Phase II Study of ASP7991 -A Double-blind, Cinacalcet Hydrochloride-controlled, Dose-ascending Study in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis -
Clinicaltrials.gov Identifier NCT02133404
Compound Name ASP7991
Medical Indication or Disease Chronic kidney disease
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 14-Mar-2014
Study Completion Date 10-Nov-2014
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS